FR2752737B1 - Comprime a liberation controlee de chlorhydrate d'alfuzosine - Google Patents

Comprime a liberation controlee de chlorhydrate d'alfuzosine

Info

Publication number
FR2752737B1
FR2752737B1 FR9610551A FR9610551A FR2752737B1 FR 2752737 B1 FR2752737 B1 FR 2752737B1 FR 9610551 A FR9610551 A FR 9610551A FR 9610551 A FR9610551 A FR 9610551A FR 2752737 B1 FR2752737 B1 FR 2752737B1
Authority
FR
France
Prior art keywords
controlled release
release tablet
alfuzosine
hydrochloride
alfuzosine hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9610551A
Other languages
English (en)
Other versions
FR2752737A1 (fr
Inventor
Lauretta Maggi
Ubaldo Conte
Pascal Grenier
Guy Vergnault
Alain Dufour
Francois Xavier Jarreau
Clemence Rauch-Desanti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9610551A priority Critical patent/FR2752737B1/fr
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to APAP/P/1999/001470A priority patent/AP1107A/en
Priority to CZ1999655A priority patent/CZ295066B6/cs
Priority to UA99020755A priority patent/UA69374C2/uk
Priority to MXPA99001958A priority patent/MXPA99001958A/es
Priority to KR1019997001666A priority patent/KR100364328B1/ko
Priority to PCT/FR1997/001515 priority patent/WO1998008515A1/fr
Priority to TR1999/00289T priority patent/TR199900289T2/xx
Priority to RU99105730/14A priority patent/RU2183459C2/ru
Priority to US09/147,581 priority patent/US6149940A/en
Priority to EP97937651A priority patent/EP0938318B1/fr
Priority to NZ334018A priority patent/NZ334018A/xx
Priority to SI9730158T priority patent/SI0938318T1/xx
Priority to SK270-99A priority patent/SK284388B6/sk
Priority to IL12814697A priority patent/IL128146A/xx
Priority to AT97937651T priority patent/ATE200864T1/de
Priority to CNB971975582A priority patent/CN1155382C/zh
Priority to DE69704712T priority patent/DE69704712T2/de
Priority to PT97937651T priority patent/PT938318E/pt
Priority to ES97937651T priority patent/ES2159400T3/es
Priority to AU40201/97A priority patent/AU724490B2/en
Priority to EEP199900090A priority patent/EE03855B1/xx
Priority to PL331862A priority patent/PL191546B1/pl
Priority to DK97937651T priority patent/DK0938318T3/da
Priority to CA002264250A priority patent/CA2264250C/fr
Priority to HU9903428A priority patent/HU228007B1/hu
Priority to JP51133198A priority patent/JP3797388B2/ja
Priority to CNB2004100422955A priority patent/CN100335057C/zh
Priority to BRPI9713237-3A priority patent/BR9713237B1/pt
Priority to ARP970103839A priority patent/AR009312A1/es
Priority to TW086112274A priority patent/TW522023B/zh
Priority to CO97049830A priority patent/CO4920217A1/es
Priority to ZA9707766A priority patent/ZA977766B/xx
Publication of FR2752737A1 publication Critical patent/FR2752737A1/fr
Application granted granted Critical
Publication of FR2752737B1 publication Critical patent/FR2752737B1/fr
Priority to IS4964A priority patent/IS2091B/is
Priority to BG103138A priority patent/BG63768B1/bg
Priority to NO19990944A priority patent/NO326206B1/no
Priority to OA9900042A priority patent/OA10983A/fr
Priority to HK99105968A priority patent/HK1020875A1/xx
Priority to GR20010401141T priority patent/GR3036291T3/el
Priority to CY0200038A priority patent/CY2284B1/xx
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
FR9610551A 1996-08-29 1996-08-29 Comprime a liberation controlee de chlorhydrate d'alfuzosine Expired - Lifetime FR2752737B1 (fr)

Priority Applications (40)

Application Number Priority Date Filing Date Title
FR9610551A FR2752737B1 (fr) 1996-08-29 1996-08-29 Comprime a liberation controlee de chlorhydrate d'alfuzosine
PL331862A PL191546B1 (pl) 1996-08-29 1997-08-22 Tabletka farmaceutyczna do podawania doustnego o kontrolowanym uwalnianiu chlorowodorku alfuzozyny
UA99020755A UA69374C2 (uk) 1996-08-29 1997-08-22 Таблетка з регульованим вивільненням гідрохлориду алфузозину (варіанти) та фармацевтична композиція
CZ1999655A CZ295066B6 (cs) 1996-08-29 1997-08-22 Tableta s řízeným uvolňováním alfuzosinhydrochloridu a farmaceutická kompozice, která ji obsahuje
KR1019997001666A KR100364328B1 (ko) 1996-08-29 1997-08-22 알푸조신 염산염의 제어방출 정제
PCT/FR1997/001515 WO1998008515A1 (fr) 1996-08-29 1997-08-22 Comprime a liberation controlee de chlorhydrate d'alfuzosine
TR1999/00289T TR199900289T2 (xx) 1996-08-29 1997-08-22 Kontroll� alfuzosin hidroklor�r salma �zelli�ine sahip tablet.
RU99105730/14A RU2183459C2 (ru) 1996-08-29 1997-08-22 Таблетка с регулируемым высвобождением алфузозина гидрохлорида
US09/147,581 US6149940A (en) 1996-08-29 1997-08-22 Tablet with controlled release of alfuzosine chlorhydrate
EP97937651A EP0938318B1 (fr) 1996-08-29 1997-08-22 Comprime a liberation controlee de chlorhydrate d'alfuzosine
EEP199900090A EE03855B1 (et) 1996-08-29 1997-08-22 Alfusosiinhüdrokloriidi reguleeritult vabastav tablett
SI9730158T SI0938318T1 (en) 1996-08-29 1997-08-22 Tablet with controlled release of alfuzosine chlorydrate
DK97937651T DK0938318T3 (da) 1996-08-29 1997-08-22 Tablet med kontrolleret frigivelse af alfuzosinchlorhydrat
IL12814697A IL128146A (en) 1996-08-29 1997-08-22 Three layered tablet with controlled release of alfuzosin hydrochloride
AT97937651T ATE200864T1 (de) 1996-08-29 1997-08-22 Tablette mit gesteuerter freisetzung von alfuzosinhydrochlorid
CNB971975582A CN1155382C (zh) 1996-08-29 1997-08-22 阿夫唑嗪盐酸盐受控释放的片剂
DE69704712T DE69704712T2 (de) 1996-08-29 1997-08-22 Tablette mit gesteuerter freisetzung von alfuzosinhydrochlorid
PT97937651T PT938318E (pt) 1996-08-29 1997-08-22 Comprimido com libertacao controlada de cloridrato de alfuzosina
ES97937651T ES2159400T3 (es) 1996-08-29 1997-08-22 Comprimido con liberacion controlada de clorhidrato de alfuzosina
AU40201/97A AU724490B2 (en) 1996-08-29 1997-08-22 Tablet with controlled release of alfuzosin hydrochloride
APAP/P/1999/001470A AP1107A (en) 1996-08-29 1997-08-22 Tablet with controlled release of alfuzosine chlorydrate.
MXPA99001958A MXPA99001958A (es) 1996-08-29 1997-08-22 Tableta con liberacion controlada de clorhidrato de alfuzosina.
SK270-99A SK284388B6 (sk) 1996-08-29 1997-08-22 Tableta s riadeným uvoľňovaním alfuzosínhydrochloridu
CA002264250A CA2264250C (fr) 1996-08-29 1997-08-22 Comprime a liberation controlee de chlorhydrate d'alfuzosine
HU9903428A HU228007B1 (en) 1996-08-29 1997-08-22 Tablet with controlled release of alfuzosine chlorydrate
JP51133198A JP3797388B2 (ja) 1996-08-29 1997-08-22 アルフゾシン塩酸塩の放出制御錠剤
CNB2004100422955A CN100335057C (zh) 1996-08-29 1997-08-22 阿夫唑嗪盐酸盐受控释放的片剂
BRPI9713237-3A BR9713237B1 (pt) 1996-08-29 1997-08-22 comprimido de liberaÇço controlada de cloridrato de alfuzosina e composiÇço farmacÊutica compreendendo o mesmo.
NZ334018A NZ334018A (en) 1996-08-29 1997-08-22 Multilayered controlled release tablet comprising a layer of alfuzosin hydrochloride and at least one layer of hydrophillic polymers
ARP970103839A AR009312A1 (es) 1996-08-29 1997-08-25 Comprimido farmaceutico destinado a la via oral, para la liberacion controlada de clorhidrato de alfuzosina al nivel de los segmentos proximales del tracto gastrointestinal y composicion farmaceutica que comprende uno o varios comprimidos.
TW086112274A TW522023B (en) 1996-08-29 1997-08-26 Tablet with controlled release of alfuzosin hydrochloride
CO97049830A CO4920217A1 (es) 1996-08-29 1997-08-28 Comprimido de liberacion controlada de clorhidrato de alfuzosina
ZA9707766A ZA977766B (en) 1996-08-29 1997-08-28 Tablet with controlled release of alfuzosin hydrochloride.
IS4964A IS2091B (is) 1996-08-29 1999-01-29 Tafla með leysnistýringu fyrir alfúsósín klórhýdrat
BG103138A BG63768B1 (bg) 1996-08-29 1999-02-01 Таблети с контролирано освобождаване на алфузозинхидрохлорид
OA9900042A OA10983A (fr) 1996-08-29 1999-02-26 Comprimé à libération contrôlée de chlorhydrate d'alfuzosine.
NO19990944A NO326206B1 (no) 1996-08-29 1999-02-26 Farmasoytisk tablett med kontrollert frigivelse av alfuzosinhydroklorid
HK99105968A HK1020875A1 (en) 1996-08-29 1999-12-20 Tablet with controlled release of alfuzosine chlorydrate
GR20010401141T GR3036291T3 (en) 1996-08-29 2001-07-26 Tablet with controlled release of alfuzosine chlorydrate
CY0200038A CY2284B1 (en) 1996-08-29 2002-05-15 Tablet with controlled release of alfuzosine chlorydrate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9610551A FR2752737B1 (fr) 1996-08-29 1996-08-29 Comprime a liberation controlee de chlorhydrate d'alfuzosine

Publications (2)

Publication Number Publication Date
FR2752737A1 FR2752737A1 (fr) 1998-03-06
FR2752737B1 true FR2752737B1 (fr) 1998-10-02

Family

ID=9495273

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9610551A Expired - Lifetime FR2752737B1 (fr) 1996-08-29 1996-08-29 Comprime a liberation controlee de chlorhydrate d'alfuzosine

Country Status (2)

Country Link
FR (1) FR2752737B1 (fr)
ZA (1) ZA977766B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124455D0 (en) * 2001-10-11 2001-12-05 Pfizer Ltd Pharmaceutical formulations
ITMI20050391A1 (it) * 2005-03-11 2006-09-12 Ph & T S P A Formulazioni a rilascio controllato di alfuzosin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2582513B1 (fr) * 1985-05-28 1988-08-05 Synthelabo Compositions pharmaceutiques contenant de l'alfuzosine
GB9311191D0 (en) * 1993-05-29 1993-07-14 Danbiosyst Uk Controlled release drug formulation
FR2717388B1 (fr) * 1994-03-21 1996-11-22 Synthelabo Formes galéniques à libération prolongée du chlorhydrate d'alfuzosine.

Also Published As

Publication number Publication date
FR2752737A1 (fr) 1998-03-06
ZA977766B (en) 1998-02-23

Similar Documents

Publication Publication Date Title
ATE200864T1 (de) Tablette mit gesteuerter freisetzung von alfuzosinhydrochlorid
NO980240D0 (no) Paroxetin-kontrollert frigjörings-blandinger
ZA975675B (en) Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one
DK0733367T3 (da) Oral olanzapinformulering
PT988310E (pt) Derivados 4"-substituido-9-desoxo-9a-aza-9a-homoeritromicina a
EP0828751A4 (fr) Recepteur de neuropeptides humain
DE69625189D1 (de) Tablette mit gesteuerter freisetzung
DK0880892T5 (da) Midler med reguleret frigivelse
DE69623861T2 (de) Kniegelenkvollprothese
NO20001050D0 (no) Fremgangsmõte for fremstilling av en støpt artikkel
FR2752737B1 (fr) Comprime a liberation controlee de chlorhydrate d'alfuzosine
IL130209A (en) Therapeutic application of a thienylcylohexylamine derivatives
GB9505191D0 (en) Therapeutic benzoxazoles
DZ2386A1 (fr) Forme microparticulaire d'un dérivé de tétrahydropyridine
IL117465A0 (en) A pharmaceutical use of certain cystine derivatives
IL151450A0 (en) Extended release formulation of venlafazine hydrochloride
AU129688S (en) Base for bathing area
GB9515060D0 (en) Therapeutic heterocyclic compounds
FI950008A (fi) Farmaseuttinen koostumus kontrolloitua vapautumista varten
HUP0001457A3 (en) Novel therapeutic application of a thienycyclohexylamine derivative
IT240817Y1 (it) Dispositivo per l'applicazione di un rivestimento murale
ZA953792B (en) Human neuropeptide receptor
ITRE970087A0 (it) Dispositivo per l'ancoraggio di protesi dentarie
KR980000689U (ko) 목욕용 때밀이구
AU131322S (en) A set of expansion sleeves for use in a masonry anchors

Legal Events

Date Code Title Description
TP Transmission of property
CD Change of name or company name
PLFP Fee payment

Year of fee payment: 20